IMPARC
Phase NA Terminated
15 enrolled 16 charts
COCHISE
Phase 2 Terminated
18 enrolled 9 charts
Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial
Terminated
199 enrolled 8 charts
SAFE-2
Phase NA Terminated
18 enrolled 10 charts
Endoscopic Optical Coherence Tomography for Screening and Diagnosis of Colorectal Precancerous and Malignant Polyps
Phase NA Terminated
36 enrolled 9 charts
Testing the Addition of a Radiation Sensitizing Drug, IPdR, to the Usual Chemotherapy Treatment (Capecitabine) During Radiation Therapy for Rectal Cancer
Phase 1 Terminated
1 enrolled 7 charts
Talimogene Laherparepvec, Chemotherapy, and Radiation Therapy Before Surgery in Treating Patients With Locally Advanced or Metastatic Rectal Cancer
Phase 1 Terminated
3 enrolled 9 charts
Blue and Amber Light Exposure in Patients With Rectal and Pancreatic Cancer
Phase NA Terminated
2 enrolled 4 charts
Ipilimumab and Local Radiation for Selected Solid Tumors
Phase 1 Terminated
3 enrolled 5 charts
Sacral Nerve Stimulation in Treating Low Anterior Resection Syndrome or Fecal Incontinence in Patients With Locally Advanced Rectal Cancer or Other Pelvic Cancer, the RESTORE Study
Phase 2 Terminated
3 enrolled 5 charts
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
Phase 3 Terminated
355 enrolled 11 charts
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
Phase 1/2 Terminated
82 enrolled 14 charts
PET/MR for Rectal Cancer Treatment Monitoring and Surveillance
Phase NA Terminated
14 enrolled 6 charts
SentiRect
Phase NA Terminated
15 enrolled 14 charts
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer
Phase 1 Terminated
6 enrolled 11 charts
Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer
Phase 1 Terminated
4 enrolled 6 charts
A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum
Phase 1 Terminated
1 enrolled 7 charts
GCC 1314
Phase 2 Terminated
3 enrolled 8 charts
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
Phase 2 Terminated
7 enrolled 5 charts
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase NA Terminated
3 enrolled 8 charts
BrUOG 302:BYL719, Capecitabine and Radiation for Rectal Cancer: A Brown University Oncology Research Group Study
Phase 1 Terminated
7 enrolled 7 charts
Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer
Phase 1/2 Terminated
32 enrolled 18 charts
PILLAR III
Phase NA Terminated
347 enrolled 18 charts
MK-0646-025
Phase 2 Terminated
11 enrolled 8 charts
Phase II Trial of Neoadjuvant FOLFOX4 and Cetuximab for Localized Adenocarcinoma of Rectum
Phase 2 Terminated
6 enrolled 7 charts
Cetuximab, 5-FU and Radiation as Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
Phase 2 Terminated
13 enrolled 9 charts
PARAGON
Phase 1/2 Terminated
4 enrolled 5 charts
Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses
Phase NA Terminated
258 enrolled 10 charts
Neo-Adjuvant FOLFOX for Rectal Carcinoma
Phase 2 Terminated
2 enrolled 4 charts
Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation
Phase 2/3 Terminated
4 enrolled 5 charts
ADAPT
Phase 2 Terminated
27 enrolled 10 charts
A Phase 1-2 Trial of Cetuximab in Combination With Oxaliplatin, Capecitabine, and Radiation Therapy Followed by Surgery for Locally-advanced Rectal Cancer
Phase 1/2 Terminated
23 enrolled 18 charts
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Phase 3 Terminated
32 enrolled 14 charts
Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Phase 2 Terminated
7 enrolled 1 chart
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
Phase 2 Terminated
5 enrolled 6 charts
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer
Phase 2 Terminated
25 enrolled 10 charts
Irinotecan and Cediranib in Treating Patients With Metastatic Colorectal Cancer That Did Not Respond to Previous Oxaliplatin, Fluoropyrimidine, and Bevacizumab
Phase 2 Terminated
5 enrolled 5 charts
Trial for Microarray Analysis of Colon Cancer Outcome-A (MACCO-A)
Phase 2 Terminated
65 enrolled 8 charts
Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer
Phase 2 Terminated
2 enrolled 4 charts
Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer
Phase 2 Terminated
1 enrolled 2 charts
Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia
Phase 1/2 Terminated
5 enrolled 7 charts
Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer
Phase 2 Terminated
22 enrolled 10 charts
Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer
Phase 2 Terminated
1 enrolled 4 charts
Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Phase 2 Terminated
39 enrolled 9 charts
Radial Reload Open LAR Case Series
Phase NA Terminated
8 enrolled 15 charts
Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy
Phase 2 Terminated
1 enrolled 7 charts
Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment
Phase 2 Terminated
13 enrolled 5 charts
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
Phase 3 Terminated
72 enrolled 15 charts
High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer
Phase 2 Terminated
10 enrolled 6 charts
Bevacizumab and Capecitabine as First-Line Therapy in Treating Older Patients With Metastatic Colorectal Cancer
Phase 2 Terminated
16 enrolled 6 charts